NCT00215891View on ClinicalTrials.gov

PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

Not specified

Conditions
Chronic Hepatitis C Infection in HIV-Infected PersonsHIV Infections
Interventions
DRUG

PEG-Interferon a-2b + Ribavirin

Trial Locations (1)

21231-1001

Johns Hopkins University School of Medicine, Baltimore

Sponsors
All Listed Sponsors
collaborator

Integrated Therapeutics Group

INDUSTRY

collaborator

Subsidiary of Schering-Plough

UNKNOWN

lead

Hepatitis Resource Network

OTHER

NCT00215891 - PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon | Biotech Hunter | Biotech Hunter